Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Parkin

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Journal of Virology|June 28, 2003
Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infectionViviana Simon, Neal Padte, Deya Murray, et al.
Microbiology Spectrum|October 31, 2022
Multisite Performance Evaluation of the cobas 5800 System and Comparison to the cobas 6800/8800 Systems for Quantitative Measurement of HBV, HCV, and HIV-1 Viral LoadJakob Tschäpe, Anika Cobernuss-Rahn, Sean Boyle, et al.
AIDS (London, England)|July 29, 2004
Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistanceLisa Ross, Neil Parkin, Colombe Chappey, et al.
AIDS (London, England)|July 20, 2002
Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individualsViviana Simon, Jeroen Vanderhoeven, Arlene Hurley, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus compositionSigne Fransen, Gary Bridger, Jeannette M Whitcomb, et al.
AIDS Research and Human Retroviruses|March 21, 2006
Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutationsSusan H Eshleman, Dana Jones, Justin Galovich, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
Interplay between single resistance-associated mutations in the HIV-1 protease and viral infectivity, protease activity, and inhibitor sensitivityGavin J Henderson, Sook-Kyung Lee, David M Irlbeck, et al.
Journal of Virology|March 21, 2008
Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope proteinWei Huang, Jonathan Toma, Signe Fransen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2006
Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibilityLisa L Ross, Neil Parkin, Peter Gerondelis, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapineDana Jones, Neil Parkin, Sarah E Hudelson, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Journal of Virology|June 28, 2003
Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infectionViviana Simon, Neal Padte, Deya Murray, et al.
Microbiology Spectrum|October 31, 2022
Multisite Performance Evaluation of the cobas 5800 System and Comparison to the cobas 6800/8800 Systems for Quantitative Measurement of HBV, HCV, and HIV-1 Viral LoadJakob Tschäpe, Anika Cobernuss-Rahn, Sean Boyle, et al.
AIDS (London, England)|July 29, 2004
Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistanceLisa Ross, Neil Parkin, Colombe Chappey, et al.
AIDS (London, England)|July 20, 2002
Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individualsViviana Simon, Jeroen Vanderhoeven, Arlene Hurley, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
Suppression of dualtropic human immunodeficiency virus type 1 by the CXCR4 antagonist AMD3100 is associated with efficiency of CXCR4 use and baseline virus compositionSigne Fransen, Gary Bridger, Jeannette M Whitcomb, et al.
AIDS Research and Human Retroviruses|March 21, 2006
Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutationsSusan H Eshleman, Dana Jones, Justin Galovich, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
Interplay between single resistance-associated mutations in the HIV-1 protease and viral infectivity, protease activity, and inhibitor sensitivityGavin J Henderson, Sook-Kyung Lee, David M Irlbeck, et al.
Journal of Virology|March 21, 2008
Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope proteinWei Huang, Jonathan Toma, Signe Fransen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2006
Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibilityLisa L Ross, Neil Parkin, Peter Gerondelis, et al.
AIDS Research and Human Retroviruses|June 10, 2005
Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapineDana Jones, Neil Parkin, Sarah E Hudelson, et al.
Pageof 7